GlassScriptPhysician profile
Laxman Ramani
NPI 1447231204
$13,932.36
in general payments reported to CMS, 2019-2025
43 companies · $2,419 in 2025
The $2,419 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $478 · 2021: $789 · 2022: $770 · 2023: $8,577 · 2024: $440 · 2025: $2,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,411 · Food and Beverage: $2,238 · Travel and Lodging: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,411.44 |
| Food and Beverage | $2,238.19 |
| Travel and Lodging | $786.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,505.06 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $781.99 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $502.27 | 2021-2025 | |
| Astellas Pharma US INC | $450.68 | 2021-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $309.73 | 2019-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $206.58 | 2019-2025 | |
| Boston Scientific Corporation | $172.91 | 2019-2023 | Solyx Sis System |
| Coopersurgical, INC. | $169.44 | 2019-2024 | Paragard T 380a, Mara Console |
| Gynesonics, INC. | $146.45 | 2021 | |
| Biogen, INC. | $137.59 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $124.12 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $117.71 | 2020-2025 | Slynd |
| Shield Therapeutics INC | $112.48 | 2023-2024 | Accrufer |
| Millicent US INC | $108.58 | 2020-2025 | Femring, Intrarosa |
| Mylan Pharmaceuticals INC. | $98.48 | 2019-2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $94.77 | 2023 | Desara |
| Optumhealth Care Solutions, LLC | $84.04 | 2023-2025 | Vivify Health Care Team Portal, Zyno Solutions, Eitan Medical |
| Organon LLC | $74.18 | 2022-2025 | Nexplanon |
| Evofem Biosciences, INC. | $67.92 | 2021-2022 | |
| Amgen INC. | $66.21 | 2020-2023 | Evenity, Prolia |
| Therapeuticsmd, INC. | $64.82 | 2020-2021 | |
| Hologic Sales and Service, LLC | $55.71 | 2019-2024 | Acessa Provu System |
| Pfizer INC. | $51.90 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $35.37 | 2019-2020 | |
| Agile Therapeutics, INC. | $33.04 | 2021-2023 | Twirla |
| Monaghan Medical Corporation | $31.39 | 2024 | Aerochamber |
| Radius Health, INC. | $29.60 | 2020 | |
| Scynexis, INC. | $28.86 | 2022 | |
| Lupin INC. | $25.23 | 2019 | |
| Avion Pharmaceuticals | $25.18 | 2019-2020 | |
| Northgate Technologies, INC. | $22.66 | 2024 | Stimsite |
| Dexcom, INC. | $22.40 | 2025 | Dexcom G6 Transmitter |
| Pacira Pharmaceuticals Incorporated | $21.30 | 2022 | |
| Becton, Dickinson and Company | $19.76 | 2023 | Bd Onclarity |
| Femselect INC. | $18.49 | 2025 | Enplace |
| Lilly USA, LLC | $17.90 | 2025 | Zepbound |
| Ethicon US, LLC | $16.47 | 2025 | Harmonic |
| Baxter Healthcare | $15.47 | 2023 | Seprafilm |
| Medtronic, INC. | $15.21 | 2021 | |
| Myovant Sciences INC. | $14.30 | 2021 | |
| Novo Nordisk INC | $14.01 | 2021 | |
| Avanos Medical | $12.58 | 2019 | |
| Channel Medsystems, INC. | $9.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laxman Ramani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.